Key Developments: GlaxoSmithKline SAE (BIOC.CA)
9.46EGP
23 May 2013
£-0.25 (-2.57%)
£9.71
£9.46
£9.46
£9.46
912
1,759
£14.82
£7.92
Latest Key Developments (Source: Significant Developments)
GlaxoSmithKline SAE Announces Cash Dividend Distribution Date for FY 2012
GlaxoSmithKline SAE announced that its Board of Directors has approved the distribution of EGP 0.75 per share as cash dividend for the fiscal year ending December 31, 2012, to be paid on June 6, 2013. The dividend date is June 3, 2013. Full Article
GlaxoSmithKline SAE Recommends Cash Dividends for FY 2012
GlaxoSmithKline SAE announced that its Board of Directors has recommended the distribution of 7.5% of the Company's nominal share value as cash dividends, which is equivalent to EGP 0.75 per share for the fiscal year 2012. Full Article
Glaxo Smith Kline Recommends Cash Dividends for FY 2011
Glaxo Smith Kline announced that its Board of Directors has recommended the distribution of 7.5% of the Company's nominal share value as cash dividends, which is equivalent to EGP 0.75 per share for the fiscal year 2011. Full Article
DAIICHI SANKYO CO., LTD. to Establish New Joint Venture with Glaxo Smith Kline K.K.
DAIICHI SANKYO CO., LTD. announced that it will establish a new joint venture, which will be engaged in the development and sale of preventive vaccine in Tokyo, Japan, with Glaxo Smith Kline K.K., effective April 2, 2012. The joint venture will be capitalized at JPY 100 million, and will start businesses effective July 2, 2012. DAIICHI SANKYO and Glaxo Smith Kline K.K., will hold 50% and 50% stakes in the joint venture, respectively. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
